You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Malignant Melanoma

Showing 26 - 50 of 7,605
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diagnostic Precision of AI Tool Dermalyzer to Identify Malignant

Recruiting
  • Malignant Melanoma
  • Dermalyzer
  • Linköping, Docent, Sweden
  • +2 more
May 12, 2022

Cutaneous Malignant Melanoma Trial in Cleveland (Low Dose Rate Brachytherapy (LDR), Standard-of-Care Immunotherapy)

Recruiting
  • Cutaneous Malignant Melanoma
  • Low Dose Rate Brachytherapy (LDR)
  • Standard-of-Care Immunotherapy
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Aug 10, 2022

Malignant Melanoma, Melanoma (Skin), Melanoma Stage III Trial in United Kingdom (SCIB1 DNA vaccine)

Recruiting
  • Malignant Melanoma
  • +3 more
  • SCIB1 DNA vaccine
  • Cardiff, United Kingdom
  • +6 more
Dec 7, 2022

Melanoma, Malignant Melanoma Trial in Stockholm (Immunostimulating Interstitial Laser Thermotherapy)

Terminated
  • Melanoma
  • Malignant Melanoma
  • Immunostimulating Interstitial Laser Thermotherapy
  • Stockholm, Sweden
    Karolinska University Hospital Solna
Jul 2, 2021

Pre Transplantation Melanoma

Completed
  • Malignant Melanoma
  • patient with melanoma pre transplantation
  • Lyon, Rhone, France
    service de dermatologie - hopital Edouard Herriot
Dec 9, 2021

Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)

Terminated
Has Results
  • Malignant Melanoma
  • Brain Metastases
  • Tucson, Arizona
    University of Arizona Cancer Center
Mar 5, 2022

Malignant Melanoma Trial (Tislelizumab)

Not yet recruiting
  • Malignant Melanoma
  • (no location specified)
Jun 15, 2021

Malignant Melanoma Trial in Milan (Pembrolizumab)

Recruiting
  • Malignant Melanoma
  • Pembrolizumab
  • Milan, Italy
    IEO Istituto Europeo di Oncologia
May 12, 2022

Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +9 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 4, 2023

Malignant Melanoma Trial in Aurora (Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab)

Recruiting
  • Malignant Melanoma
  • Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab
  • Aurora, Colorado
    University of Colorado Hospital
May 25, 2022

GI Complications in Cancer Immunotherapy Patients

Recruiting
  • Malignant Melanoma
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 4, 2022

    Melanoma Trial in Germany (PTK787/ZK 222584, Dacarbazine)

    Terminated
    • Melanoma
    • Essen, Germany
    • +3 more
    Sep 28, 2021

    Skin Cancer, Malignant Melanoma Trial in Copenhagen (Reflectance confocal microscopy (RCM), Photoacoustic imaging (PAI) and

    Recruiting
    • Skin Cancer
    • Malignant Melanoma
    • Reflectance confocal microscopy (RCM), Photoacoustic imaging (PAI) and tape-strippng of RNA and lipids
    • Copenhagen, Denmark
      Dept of Dermatology
    May 20, 2022

    Vitamin D Status in Anti-PD1 Treated Melanoma Patients

    Completed
    • Malignant Melanoma
    • Aarhus, Denmark
      AUH
    Feb 16, 2022

    Malignant Melanoma, Gynecologic Cancer Trial in Pavia (carbon ion radiation therapy CIRT)

    Recruiting
    • Malignant Melanoma
    • Gynecologic Cancer
    • carbon ion radiation therapy CIRT
    • Pavia, Italy
      CNAO
    Jul 27, 2022

    Malignant Melanoma Trial in Norway (Blood sampling for Pre-existing immunity, Ipilimumab)

    Active, not recruiting
    • Malignant Melanoma
    • Bergen, Norway
    • +7 more
    Oct 22, 2021

    Tafinlar® + Mekinist® (Dabrafenib + Trametinib)

    Recruiting
    • Malignant Melanoma
    • dabrafenib + trametinib
    • Coimbra, Center, Portugal
    • +5 more
    Jun 9, 2022

    Registry of Subjects at Risk of Pancreatic Cancer

    Recruiting
    • Familial Pancreatic Cancer
    • +6 more
    • MRCP
    • Endoultrasonography
    • Rozzano, Milan, Italy
    • +3 more
    Jan 12, 2023

    Malignant Melanoma Trial in Oslo (Ipilimumab, UV1 vaccine, GM-CSF)

    Active, not recruiting
    • Malignant Melanoma
    • Oslo, Norway
      Oslo University Hospital, Radiumhospitalet
    May 14, 2021

    Malignant Melanoma Trial (tremelimumab/durvalumab, ipilimumab/nivolumab and nivolumab monotherapy)

    Withdrawn
    • Malignant Melanoma
    • tremelimumab/durvalumab, ipilimumab/nivolumab and nivolumab monotherapy
    • (no location specified)
    Nov 12, 2021

    Melanoma Trial in Australia, New Zealand, United Kingdom (NY-ESO-1 ISCOMATRIX®, ISCOMATRIX® adjuvant)

    Completed
    Has Results
    • Melanoma
    • NY-ESO-1 ISCOMATRIX®
    • ISCOMATRIX® adjuvant
    • Camperdown, New South Wales, Australia
    • +14 more
    Oct 3, 2022

    Gastric Adenocarcinoma, Malignant Melanoma Trial in Seoul (AZD6738, Durvalumab)

    Active, not recruiting
    • Gastric Adenocarcinoma
    • Malignant Melanoma
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Newly Diagnosed or Recurrent Metastatic Melanoma Patients, Malignant Brain Tumors Trial in New York (PET scan with

    Active, not recruiting
    • Newly Diagnosed or Recurrent Metastatic Melanoma Patients
    • Malignant Brain Tumors
    • PET scan with 124I-cRGDY-PEG-dots
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 13, 2022

    Melanoma Trial in France, Spain (BO-112 and Pembrolizumab, Tissue Biopsies)

    Active, not recruiting
    • Melanoma
    • BO-112 and Pembrolizumab
    • Tissue Biopsies
    • Bordeaux, France
    • +18 more
    Dec 9, 2022

    Malignant Melanoma Stage III Trial in Worldwide (Ipilimumab, Nivolumab, Surgery)

    Active, not recruiting
    • Malignant Melanoma Stage III
    • Sydney, New South Wales, Australia
    • +3 more
    Apr 14, 2022